Infectious Diseases
FDA approves Lenacapavir: What it means for HIV prevention
We asked an expert about the new HIV prevention drug — here's what she said
Top Stories
-
Diabetes and EndocrinologyAPRIL 03, 2025UC Davis Health launches new cell therapy trial for chronic kidney disease patients
A new clinical trial at UC Davis Health is investigating cell therapy for patients with Chronic Kidney Disease caused by type 2 diabetes.
Read More -
GI and Liver HealthMARCH 13, 2025Novel endoscopic procedure helps patient avoid surgery
UC Davis Medical Center is the first hospital in Sacramento to remove a tumor from the lining of a patient’s stomach without resorting to surgery.
Read More -
Internal MedicineFEBRUARY 26, 2025The next pandemic: COVID-19 showed us how we can fight the next global outbreak
UC Davis Health Chief of Infectious Diseases Stuart Cohen shares how the lessons of COVID-19 have helped us prepare for the next pandemic.
Read More -
RheumatologyFEBRUARY 25, 2025New study provides clinicians a more comprehensive view of psoriatic arthritis and other autoimmune arthritis
Researchers rely on a new technology to better assess inflammation in a patient’s entire body and treat autoimmune arthritis.
Read More -
Internal MedicineFEBRUARY 21, 2025Could chemical compounds improve metabolism and reduce inflammation?
A new study by nephrology researchers has identified two compounds that could potentially help improve metabolic health.
Read More